Digital Event on Orphan Drugs and Rare Diseases
The “2nd Edition Digital Event on Orphan Drugs and Rare Diseases (GMT)”, a virtual meeting place for the rare disease
Category: Pharma applications
Utility of aspirin in hospitalized COVID-19 patients
A recent paper published in Anesthesia & Analgesia Journal evaluated the possible benefits of using aspirin in hospitalized COVID-19 patients
Inclusion complex based on N-acetyl-L-cysteine and arginine modified hydroxypropyl-β-cyclodextrin for oral insulin delivery
Insulin is the most effective drug in the treatment of diabetes mellitus. At present, subcutaneous injection is still the common
Alpha-CD-containing oral spray to inhibit the SARS-CoV-2 endocytosis
Italian researchers developed an oral spray (Endovir Stop) containing alpha-cyclodextrin (0.2%) and hydroxytyrosol (3.8%) for the improvement of the defenses
Oxidized CD bisulfite against influenza A virus
Previous reports have demonstrated that compounds based on sulfo derivatives of oligo- and polysaccharides possess high antiviral activity. In this
Cholesterol chelator, HPβCD for renal diseases
There is increasing evidence that accumulation of intracellular lipids in the kidney contributes to the pathogenesis and progression of kidney
FIRST EXPERIMENTS IN SPACE FOR COVID-19 DRUG RESEARCH
The COVID-19 pandemic has generated new and urgent challenges in drug discovery and development. Veklury®, a remdesivir-based medicament invented by
Pfizer and BioNTech announced vaccine candidate against covid-19 achieved success in first interim analysis from Phase 3 study
Pfizer’s Early Data Shows Vaccine Is More Than 90% Effective Pfizer and BioNTech announced on 09 October their mRNA-based vaccine
Sedor Pharmaceuticals Receives FDA Approval for SESQUIENT™ (SBECD-enabled fosphenytoin)
Ligand Pharmaceuticals Incorporated announced that its partner Sedor Pharmaceuticals, LLC has received approval from the U.S. Food and Drug Administration
Global Conference on Pharmaceutical Research and Drug Development
Global Conference on Pharmaceutical Research and Drug Development (GPD 2021) has been scheduled during May 14-15, 2021 at Prague, Czech republic with indeed focus on the